Xenna Corporation, a New Jersey-based and women-owned leader in science-driven personal care, has announced positive results from a recent clinical study evaluating the effectiveness of its CalmScalp® Topical Solution. The product, developed to relieve common scalp concerns such as irritation, flaking, redness, and dryness, represents a significant advancement in gentle, steroid-free scalp care.
CalmScalp® was designed to provide relief for individuals dealing with chronic scalp discomfort without the use of harsh medications or corticosteroids. The new study results highlight its success in addressing these issues safely and effectively, offering an alternative for those seeking a natural but clinically backed solution. As consumers become increasingly mindful of the ingredients in their skincare and haircare products, Xenna’s innovation arrives at a pivotal time for the health and wellness community.
The study revealed that consistent use of CalmScalp® led to noticeable reductions in scalp irritation and flaking, with many participants reporting visible improvements in overall scalp comfort and appearance. The formulation works to restore balance to the scalp’s natural barrier, helping to calm inflammation while supporting healthier skin and hairline function. This makes it an attractive option for those experiencing sensitivity due to weather changes, hair styling products, or underlying conditions like seborrheic dermatitis.
What distinguishes CalmScalp® from many traditional scalp treatments is its steroid-free composition. Many over-the-counter and prescription solutions rely on corticosteroids, which can deliver short-term relief but may cause long-term sensitivity or thinning with prolonged use. Xenna’s approach is rooted in scientific research and dermatological safety, utilizing soothing, non-toxic ingredients designed to deliver lasting benefits without harmful side effects.
Founded and operated by women, Xenna Corporation has built its reputation on creating effective, science-based wellness products that prioritize both performance and safety. The company’s commitment to research and quality control has made it a trusted name in the personal care sector, with a focus on products that address real health concerns through innovative, clinically tested solutions.
The positive results of the CalmScalp® study not only reinforce Xenna’s scientific credibility but also highlight the growing demand for wellness products developed with integrity and transparency. As more consumers shift toward clean, dermatologically sound solutions, CalmScalp® stands out as a product that bridges the gap between clinical performance and gentle care.
The company plans to continue expanding its line of science-backed personal care products, building on the success of CalmScalp® to address other common skin and hair health concerns. With New Jersey continuing to serve as a center for medical and cosmetic innovation, Xenna’s latest breakthrough underscores the state’s role in advancing smarter, safer, and more effective health solutions for all.
For more stories on health innovations and wellness advancements across New Jersey, visit Explore New Jersey’s Health & Wellness section.
